Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you take an oral contraceptive and you're considering Wegovy, the short answer is: the evidence is reassuring, but there are practical steps worth knowing before you start. Semaglutide slows how quickly food and liquid leave your stomach, and there's a theoretical concern that this could affect how well a pill is absorbed. Clinical guidance from NHS England's weight-management-injections page acknowledges this interaction but notes that — unlike with tirzepatide — there is no strong evidence that semaglutide significantly reduces the effectiveness of oral contraceptives. That said, this is a prescription-only medicine, and your prescriber is the right person to weigh up your specific contraception and health picture before you begin.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by slowing how fast the stomach empties. In theory, any medicine that does this could delay or reduce the absorption of an oral contraceptive taken at the same time. It's a question our prescribers hear most weeks, and understandably so, the stakes feel high.
In practice, NHS England's guidance makes a distinction that matters here. It explicitly notes there is no equivalent evidence of reduced pill effectiveness for semaglutide, in contrast to the specific advice it gives for tirzepatide. So the theoretical concern exists, but the clinical evidence for semaglutide does not support the same additional precautions that tirzepatide users are advised to take. You can read the full detail on how Wegovy interacts with the contraceptive pill for a closer look at what the current guidance says.
That distinction matters if you're deciding between the two weight-loss injections. It's also worth knowing that semaglutide tablets follow a slightly different pharmacokinetic profile to the injection, and if you're considering that route and want to know where to source it, our guide to where to buy the Wegovy pill in the UK covers what's known so far.
The core decision facing most people at this point is not whether semaglutide definitely interferes with the pill, but how to have an informed conversation with their prescriber about their specific contraception before they start. NHS guidance is clear that Wegovy is not suitable during pregnancy, and because unintended pregnancies can happen, effective contraception throughout treatment is important.
If you use a combined oral contraceptive or a progestogen-only pill, mention it specifically during your consultation. A prescriber may want to consider the timing of your pill relative to your injection day, or whether a long-acting method might remove the question entirely. This is particularly relevant for anyone whose pill absorption is already variable, for instance, if you experience frequent vomiting as a side effect in the early weeks of treatment.
For a broader picture of how semaglutide behaves in people without diabetes, the page on oral semaglutide for weight loss covers the clinical evidence in more depth. And if you want to explore all your weight-management options before deciding, our treatment overview sets them out clearly.
Wegovy is not recommended in pregnancy, during breastfeeding, or when actively trying to conceive. This is not a precautionary footnote, it reflects the absence of safety data in these groups, and the MHRA and manufacturers are clear on it. Anyone planning a pregnancy should discuss with their prescriber how far in advance of trying to conceive they should stop treatment, because a wash-out period is advised.
This makes reliable contraception an active part of treatment, not an afterthought. If your current method is the pill and you have any doubts about its reliability alongside Wegovy, that conversation belongs in your consultation rather than after you've started. Semaglutide is a prescription-only medicine reviewed by an NHS medicines team, and the patient information leaflet covers contraception guidance in its full form, your prescriber can talk you through the relevant section.
Under-18s are not a licensed group for this treatment. If you're unsure where you stand on eligibility more broadly, starting a free consultation is the clearest way to get a clinical answer for your situation.
General guidance can only go so far. The pill is not one thing, it covers combined pills, progestogen-only pills, different formulations and different brands, and your personal health history adds another layer. The same applies to other oral medications you may take.
A GPhC-registered prescriber reading your full consultation gives you a more useful answer than any article can. At nume, every consultation is reviewed by a real clinician (not processed automatically) and our clinical team can address contraception questions directly as part of that review. If you want to read more before you begin, the semaglutide and contraceptive pill page goes further into the evidence, and our general FAQs cover some of the most common pre-consultation questions. Ready to talk it through properly? Check your eligibility and one of our prescribers will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.